These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19475756)

  • 21. Farming and incidence of motor neuron disease: French nationwide study.
    Kab S; Moisan F; Elbaz A
    Eur J Neurol; 2017 Sep; 24(9):1191-1195. PubMed ID: 28727213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Swedish motor neuron disease quality registry.
    Longinetti E; Regodón Wallin A; Samuelsson K; Press R; Zachau A; Ronnevi LO; Kierkegaard M; Andersen PM; Hillert J; Fang F; Ingre C
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):528-537. PubMed ID: 30296856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of motor neurone disease within MidCentral Region, New Zealand.
    Caulfield A; Cariga P
    N Z Med J; 2018 Nov; 131(1485):48-51. PubMed ID: 30408817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological characteristics of motor neuron disease in Chinese patients.
    Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
    Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor neuron disease: a disease of old age.
    Chancellor AM; Hendry A; Caird FI; Warlow CP; Weir AI
    Scott Med J; 1993 Dec; 38(6):178-82. PubMed ID: 8146636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and prevalence of motor neurone disease in South Australia.
    Luker J; Woodman R; Schultz D
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):195-202. PubMed ID: 35934980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of motor nueron disease in Scotland.
    Forbes RB; Colville S; Parratt J; Swingler RJ
    J Neurol; 2007 Jul; 254(7):866-9. PubMed ID: 17420925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.
    Mehal JM; Holman RC; Schonberger LB; Sejvar JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):346-52. PubMed ID: 23621426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An epidemiological study of motor neuron disease in Hong Kong.
    Fong GC; Cheng TS; Lam K; Cheng WK; Mok KY; Cheung CM; Chim CS; Mak W; Chan KH; Tsang KL; Kwan MC; Tsoi TH; Cheung RT; Ho SL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):164-8. PubMed ID: 16247937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and epidemiological features of motor neuron disease in south-western Greece.
    Argyriou AA; Polychronopoulos P; Papapetropoulos S; Ellul J; Andriopoulos I; Katsoulas G; Salakou S; Chroni E
    Acta Neurol Scand; 2005 Feb; 111(2):108-13. PubMed ID: 15644070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of motor neurone disease in the Province of Alberta.
    Svenson LW; Cwik VA; Martin WR
    Can J Neurol Sci; 1999 May; 26(2):119-22. PubMed ID: 10352871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential features of motor neuron disease mortality in Spain.
    Veiga-Cabo J; Almazán-Isla J; Sendra-Gutiérrez JM; de Pedro-Cuesta J
    Int J Epidemiol; 1997 Oct; 26(5):1024-32. PubMed ID: 9363524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying key signs of motor neurone disease in primary care: a nested case-control study using the QResearch database.
    Mei XW; Burchardt J; Ranger TA; McDermott CJ; Radunovic A; Coupland C; Hippisley-Cox J
    BMJ Open; 2022 Jun; 12(6):e058383. PubMed ID: 35768081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands.
    de Jongh AD; van Eijk RPA; Peters SM; van Es MA; Horemans AMC; van der Kooi AJ; Voermans NC; Vermeulen RCH; Veldink JH; van den Berg LH
    Neurology; 2021 Feb; 96(8):e1227-e1236. PubMed ID: 33472922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor neuron disease on Guam: geographic and familial occurrence, 1956-85.
    Zhang ZX; Anderson DW; Mantel N; Román GC
    Acta Neurol Scand; 1996 Jul; 94(1):51-9. PubMed ID: 8874594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor neuron disease in the Padua district of Italy: an epidemiological study.
    Briani C; Marcon M; Dam M; Beghi E; Pegoraro E; Angelini C
    Neuroepidemiology; 1996; 15(4):173-9. PubMed ID: 8817499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Record linkage between hospital discharges and mortality registries for motor neuron disease case ascertainment for the Spanish National Rare Diseases Registry.
    Ruiz E; Ramalle-Gómara E; Quiñones C;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):275-8. PubMed ID: 24641576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000.
    Hughes RA; Charlton J; Latinovic R; Gulliford MC
    Arch Intern Med; 2006 Jun; 166(12):1301-4. PubMed ID: 16801513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.